ETIOLOGY, PREVENTION, AND TREATMENT OF HEPATOCELLULAR CARCINOMA (P01) (NCI) (PAR-09-147)
Application Receipt/Submission Date(s): May 28, 2009; September 29, 2009; January 28, 2010; May 28, 2010; September 28, 2010; January 28, 2011; and May 27, 2011
This FOA encourages research activities in the broad areas of etiology and etiologic mechanism(s) of liver cancer, which include, but are not limited to: (a) identification of viral and host factors in initiation of HCC; (b) examination of the development of HCC in the sequelae of viral infection; (c) development of animal models and in vitro virus cultivation methods; (d) development of prevention and control strategies, including chemoprevention; (e) validation of markers; (f) preclinical or clinical trials of promising agents; and (g) imaging studies for diagnosis and intervention.
TRANSLATIONAL RESEARCH IN PEDIATRIC AND OBSTETRIC PHARMACOLOGY(NICHD) (R03: PAR-09-154) (R01: PAR-09-155) (R21: PAR-09-156)
Letters of Intent Receipt Date(s): August 17, 2009
Application Receipt/Submission Date(s): September 16, 2009, January 19, 2010, May 19, 2010, September 16, 2010, January 19, 2011, May 19, 2011
This funding opportunity announcement issued by the Obstetric and Pediatric Pharmacology Branch (OPPB) (http://www.nichd.nih.gov/about/org/crmc/opp/), Center for Research for Mothers and Children at the Eunice Kennedy Shriver National Institute of Child Health and Human Development encourages research grant applications to conduct studies to improve existing drug safety and efficacy, and to develop new drugs for pediatric and obstetric populations. The overall goals of this FOA are to support: (1) pharmacological studies addressing the special differences of drug actions and responses among children at various developmental stages, between children and adults, and between pregnant and non-pregnant women; (2) development of new drug targeting children and pregnant women; (3) multidisciplinary collaborations between basic and physician scientists to improve the use of therapeutics in obstetrics and pediatrics. Examples of research topics include applying imaging tools such as magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT) to assess the drug effects and clinical outcomes of pediatric and obstetric patients.
URL for R03: http://grants.nih.gov/grants/guide/pa-files/PAR-09-154.html
URL for R01: http://grants.nih.gov/grants/guide/pa-files/PAR-09-155.html
URL for R21: http://grants.nih.gov/grants/guide/pa-files/PAR-09-156.html
RECOVERY ACT NOTICE: NIH ARRA FUNDING CONSIDERATIONS FOR APPLICATIONS WITH MERITORIOUS SCORES THAT FALL BEYOND THE PAY-LINE (NOT-OD-09-078)
ARRA ADMINISTRATIVE SUPPLEMENTS AND COMPETITIVE REVISIONS: CLARIFICATIONS ON PROGRAMMATIC LIMITATIONS AND USE OF MODULAR BUDGETS (NIH) (NOT-OD-09-079)
RECOVERY ACT OF 2009: NIH AWARD TERMS AND ADDITIONAL INFORMATION FOR RECIPIENTS RECEIVING RECOVERY ACT GRANT FUNDING (NIH) (NOT-OD-09-080)
The ARRA requires recipients to separately account for, track, monitor, report on, provide for audit of, and closeout of all grant funding provided under the ARRA. NIH, in accordance with the Department of Health and Human Services (HHS) guidance, is implementing a number of unique business processes to accommodate the separation of ARRA funding from funding provided under the standard NIH Appropriation.
NOTICE OF PUBLIC MEETING: EXPANSION OF THE CLINICAL TRIALS REGISTRY AND RESULTS DATA BANK (NIH) (NOT-OD-09-077)
Public Meeting Time and Date: 9:00 a.m.-5:00 p.m., Monday, April 20, 2009
Location: Masur Auditorium, NIH Clinical Center, 10 Center Drive, Building 10, South Side, First Floor, Bethesda, Maryland, 20892
Federal Register Notice: http://edocket.access.gpo.gov/2009/E9-6198.htm
NOTICE REGARDING COMPETITIVE REVISIONS USING RECOVERY ACT FUNDS FOR APPLICATIONS STILL REQUIRING PAPER SUBMISSION (NIH)(NOT-OD-09-083)
This notice provides additional guidance to applicants responding to "NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications" (NOT-OD-09-058). Specifically, this applies to competitive revisions for parent awards for which the activity code of the application has not transitioned to electronic submission.
NIH REQUIRES MANDATORY USE OF THE ERA COMMONS FINANCIAL CONFLICT OF INTEREST (FCOI) MODULE BEGINNING JULY 1, 2009 FOR NIH-FUNDED GRANTS AND/OR COOPERATIVE AGREEMENTS (NOT-OD-09-072)
17th Scientific Meeting and Exhibition, International Society for Magnetic Resonance in Medicine (ISMRM)
April 18-24, 2009, Honolulu, Hawaii.
Frontiers of Biomedical Imaging Science
Vanderbilt, June 3-5, 2009, Vanderbilt University Student Life Center, Nashville, TN
SIIM 2009 Society for Imaging Informatics in Medicine
June 4-7, 2009, Charlotte, NC
Ultrasonic Imaging and Tissue Characterization
Dedicated to the memory of Robert F Wagner (1938-2008)
June 10-12, 2009, Holiday Inn Rosslyn at Key Bridge, Arlington, VA
56th Annual Society of Nuclear Medicine Meeting
June 13-17, 2009, Toronto, Ontario Canada
Session: Grantsmanship in an Era of Change, 4:30 - 6 PM June 13
NCI Cancer Imaging Program, Booth 132 on Publishers' Row
2009 NIH Regional Seminars on Program Funding and Grants Administration (NOT-OD-09-012)
The 2-day seminar provides information about the NIH funding process, from opportunity identification and application preparation through post award administration.
June 25-26, 2009, JW Marriott Hotel Resort & Spa, hosts: University of Nevada, Las Vegas and University of Nevada, Reno, Las Vegas, NV
18th International Symposium on Radiopharmaceutical Sciences
July 12-17, 2009, Edmonton, Alberta Canada
51st AAPM Annual Meeting
July 26-30, 2009, Anaheim Convention Center, Anaheim, California
American Chemical Society Fall National Meeting
Probe Development in Molecular Imaging and Therapy, August 16-20, 2009, Washington, DC
URL: http://portal.acs.org/portal/acs/corg/content and choose Meetings tab
Imaging in 2020
September 13-17, 2009, Jackson Hole, Wyoming
International Conference on the Ultrasonic Measurement and Imaging of Tissue Elasticity
September 14-17, 2009, The Netherlands
World Molecular Imaging Congress
September 23 - 26, 2009,Montreal, Quebec Canada
RSNA 2010 Clinical Trials Methodology Workshop
January 9-15, 2010, Hyatt Regency, Scottsdale, Arizona
Apply on line by June 8, 2009.